Ciltacabtagene autoleucel,Pomalidomide,Bortezomib,Dexamethasone,Daratumumab
Janssen
['mmsm']
#mmsm #asco23 i am concerned here
"no patients discontinued a trial treatment
because of drug-manufacturing failure.
the median time from the receipt of apheresis
material to product release was 44 days (range,
25 to 127) (see the supplementary appendix)."
Assistant professor @UAMSMyeloma. Alumni heme/onc @bcmhouston, clinical research/biostat @UMich.Focus on plasma cell disorders & health disparities